[EN] METHODS AND COMPOSITIONS FOR TARGETING PD-L1<br/>[FR] PROCÉDÉS ET COMPOSITIONS POUR LE CIBLAGE DE PD-L1
申请人:ALIGOS THERAPEUTICS INC
公开号:WO2021236771A1
公开(公告)日:2021-11-25
The present disclosure related to compounds that can be useful as inhibitors of PD-1, PD-Ll or the PD-1/PD-Ll interaction. Also disclosed herein are pharmaceutical compositions of that can include a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and uses of or methods of using a compound of Formula (I), or a pharmaceutically acceptable salt thereof, for the treatment of PD-L1 related diseases including but not limited to liver diseases, cancer, hepatocellular carcinoma, viral diseases, or hepatitis B.
本公开涉及可用作PD-1、PD-L1或PD-1/PD-L1相互作用抑制剂的化合物。本公开还涉及可以包括式(I)化合物或其药学上可接受的盐的药物组合物,以及使用式(I)化合物或其药学上可接受的盐治疗PD-L1相关疾病的用途或方法,包括但不限于肝病、癌症、肝细胞癌、病毒性疾病或乙型肝炎。